![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 21, 2016 11:03:16 AM
Recent PTCT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:35:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:31 PM
- PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/08/2024 08:01:00 PM
- PTC Therapeutics Announces Sepiapterin NDA Submission to FDA • PR Newswire (US) • 07/30/2024 12:00:00 PM
- PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results • PR Newswire (US) • 07/25/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 09:20:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 07:14:16 PM
- CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review • PR Newswire (US) • 06/28/2024 10:00:00 AM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/21/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:55:18 AM
- Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients • PR Newswire (US) • 06/20/2024 10:30:00 AM
- PTC Therapeutics to Participate at Upcoming Investor Conference • PR Newswire (US) • 05/29/2024 12:00:00 PM
- PTC Therapeutics Announces Validation of Sepiapterin European MAA • PR Newswire (US) • 05/28/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:20:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 02:12:33 PM
- PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation • PR Newswire (US) • 05/20/2024 04:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 11:20:54 AM
- PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation • PR Newswire (US) • 05/20/2024 11:00:00 AM
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ • PR Newswire (US) • 05/14/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:20:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2024 09:20:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2024 07:30:30 PM
- PTC Therapeutics to Participate at Upcoming Investor Conferences • PR Newswire (US) • 05/02/2024 12:00:00 PM
- PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/25/2024 08:05:00 PM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/23/2024 08:30:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM